Crystalline Forms of Androgen Receptor Modulator for Stable Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for prostate cancer and Kennedy's disease, particularly those targeting the androgen receptor, are limited in effectiveness, and there is a need for more stable and pure pharmaceutical forms of compounds like 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile for therapeutic use.
Innovation Solution
Development of crystalline forms of 3-(5-(2-hydroxy-2-methylpropoxy)-6-methylpyrazin-2-yl)-1H-indole-7-carbonitrile, characterized by X-ray powder diffraction, differential scanning calorimetry, and thermogravimetric analysis, which are stable and suitable for pharmaceutical applications, including the treatment of Kennedy's disease and modulation of androgen receptor activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If crystalline forms of the compound are developed for pharmaceutical use, then stability and purity are improved, but manufacturing complexity increases
Solution Approach 1:
The patent applies parameter changes by developing specific crystalline forms (polymorphs) of the compound with defined physical and chemical parameters. Different crystalline forms exhibit varying degrees of stability, solubility, and bioavailability. By selecting and optimizing specific crystalline forms, the patent achieves improved reliability while managing manufacturing complexity through systematic characterization and selection of optimal forms.
Solution Approach 2:
The patent employs composite materials by creating pharmaceutical compositions that combine the active compound in specific crystalline forms with excipients and other pharmaceutical ingredients. This approach enhances stability and purity while allowing flexibility in manufacturing processes through formulation optimization.
2Measurement precision
If crystalline forms are characterized using multiple analytical methods, then measurement precision is improved, but device complexity increases
Solution Approach 1:
The patent applies segmentation by dividing the characterization process into multiple independent analytical methods, each targeting specific properties of the crystalline forms. Techniques such as X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and thermogravimetric analysis (TGA) are used separately to measure different aspects (crystal structure, thermal properties, composition). This segmented approach achieves high measurement precision while allowing each method to be optimized independently.
Solution Approach 2:
The patent employs universal characterization methods that can analyze multiple properties of the crystalline forms using single techniques. For example, thermal analysis methods can simultaneously provide information about phase transitions, stability, and composition, reducing the need for multiple specialized instruments while maintaining comprehensive characterization.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The crystalline forms provide a stable and effective treatment option for Kennedy's disease and potentially for prostate cancer by modulating androgen receptor activity, offering improved therapeutic outcomes with enhanced stability and purity compared to previous forms.
Implementation Method 1
characterized by X-ray powder diffraction
Implementation Method 2
XRPD diffractogram
Implementation Method 3
differential scanning calorimetry
Implementation Method 4
thermogravimetric analysis
Data Source
AI summary
This disclosure provides crystalline forms of an androgen receptor modulator, and methods of making and using these forms.